Cannabosides Show Positive Results as Potential Colitis Treatment in Preclinical Studies

Cannabosides Show Positive Results as Potential Colitis Treatment in Preclinical Studies
A new class of ingestible cannabinoid prodrugs known as cannabosides developed to treat colitis have shown positive results in preclinical studies, Vitality Biopharma has announced. Cannabosides are a modification of a novel class of chemical compounds called cannabinoids found in the cannabis plant. By ingesting cannabosides, their action is targeted and limited to the gastrointestinal tract. Other body locations

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

One comment

Leave a Comment

Your email address will not be published. Required fields are marked *